New generation of DNA-based immunotherapy induces a potent immune response and increases the survival in different tumor models

BACKGROUND: Strategies to increase nucleic acid vaccine immunogenicity are needed to move towards clinical applications in oncology. In this study, we designed a new generation of DNA vaccines, encoding an engineered vesicular stomatitis virus glycoprotein as a carrier of foreign T cell tumor epitop...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Immunother Cancer
Autores principales: Lopes, Alessandra, Bastiancich, Chiara, Bausart, Mathilde, Ligot, Sophie, Lambricht, Laure, Vanvarenberg, Kevin, Ucakar, Bernard, Gallez, Bernard, Préat, Véronique, Vandermeulen, Gaëlle
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2021
Materias:
Oncolytic and Local Immunotherapy
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8021892/
https://ncbi.nlm.nih.gov/pubmed/33795383
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001243
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares